Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study

Background: The Cancer Genome Atlas (TCGA) Research Network revealed numerous clear cell renal cell carcinoma (ccRCC) gene mutations among which titin (TTN). The link between excessive amounts of visceral adipose tissue (VAT) and ccRCC pathogenesis is known. A relationship between VHL and TTN gene m...

Full description

Bibliographic Details
Main Authors: Federico Greco, Alessandro Tafuri, Rosario Francesco Grasso, Bruno Beomonte Zobel, Carlo Augusto Mallio
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/12/19/9502
_version_ 1797480883122339840
author Federico Greco
Alessandro Tafuri
Rosario Francesco Grasso
Bruno Beomonte Zobel
Carlo Augusto Mallio
author_facet Federico Greco
Alessandro Tafuri
Rosario Francesco Grasso
Bruno Beomonte Zobel
Carlo Augusto Mallio
author_sort Federico Greco
collection DOAJ
description Background: The Cancer Genome Atlas (TCGA) Research Network revealed numerous clear cell renal cell carcinoma (ccRCC) gene mutations among which titin (TTN). The link between excessive amounts of visceral adipose tissue (VAT) and ccRCC pathogenesis is known. A relationship between VHL and TTN gene mutations and a CT-derived estimation of body composition in ccRCC patients has been evaluated. Methods: We retrospectively assessed patients from the TCGA-kidney renal clear cell carcinoma (KIRC) database for evaluation of clinicopathological and body composition analysis of ccRCC VHL and TTN gene mutations. Results: Gene expression levels and survival were assessed on a large cohort of 483 patients and 533 tumor samples. A statistically significant difference of VHL expression reduction in primary tumor (<i>p</i> < 0.0001) and a TTN expression increase in primary tumor (<i>p</i> < 0.0001) was shown. TTN high expression levels was associated with statistically significant lower KIRC patient survival at eight years (<i>p</i> < 0.05). For body composition analysis, we included 54 male patients divided into two groups: ccRCC-VHL (<i>n</i> = 41) and ccRCC-TTN (<i>n</i> = 13) groups. Statistically significant differences between the two groups were obtained for total adipose tissue (TAT) (<i>p</i> < 0.01), VAT (<i>p</i> < 0.05), subcutaneous adipose tissue (SAT) (<i>p</i> < 0.05) and total abdominal muscle (TAM) (<i>p</i> < 0.05) areas. Conclusion: This study demonstrates a link between ccRCC TTN gene mutation and shorter patient survival. The reduction of the analyzed tissues might be a risk of cancer cachexia in ccRCC patients with TTN gene mutation.
first_indexed 2024-03-09T22:06:35Z
format Article
id doaj.art-7112756c63a244638a3bdf8bc71e3735
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-09T22:06:35Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-7112756c63a244638a3bdf8bc71e37352023-11-23T19:40:40ZengMDPI AGApplied Sciences2076-34172022-09-011219950210.3390/app12199502Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory StudyFederico Greco0Alessandro Tafuri1Rosario Francesco Grasso2Bruno Beomonte Zobel3Carlo Augusto Mallio4U.O.C. Diagnostica per Immagini Territoriale Aziendale, Cittadella Della Salute Azienda Sanitaria Locale di Lecce, Piazza Filippo Bottazzi, 73100 Lecce, ItalyDepartment of Urology, “Vito Fazzi” Hospital, Piazza Filippo Muratore, 1, 73100 Lecce, ItalyUnit of Diagnostic Imaging, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, 00128 Rome, ItalyUnit of Diagnostic Imaging, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, 00128 Rome, ItalyUnit of Diagnostic Imaging, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, 00128 Rome, ItalyBackground: The Cancer Genome Atlas (TCGA) Research Network revealed numerous clear cell renal cell carcinoma (ccRCC) gene mutations among which titin (TTN). The link between excessive amounts of visceral adipose tissue (VAT) and ccRCC pathogenesis is known. A relationship between VHL and TTN gene mutations and a CT-derived estimation of body composition in ccRCC patients has been evaluated. Methods: We retrospectively assessed patients from the TCGA-kidney renal clear cell carcinoma (KIRC) database for evaluation of clinicopathological and body composition analysis of ccRCC VHL and TTN gene mutations. Results: Gene expression levels and survival were assessed on a large cohort of 483 patients and 533 tumor samples. A statistically significant difference of VHL expression reduction in primary tumor (<i>p</i> < 0.0001) and a TTN expression increase in primary tumor (<i>p</i> < 0.0001) was shown. TTN high expression levels was associated with statistically significant lower KIRC patient survival at eight years (<i>p</i> < 0.05). For body composition analysis, we included 54 male patients divided into two groups: ccRCC-VHL (<i>n</i> = 41) and ccRCC-TTN (<i>n</i> = 13) groups. Statistically significant differences between the two groups were obtained for total adipose tissue (TAT) (<i>p</i> < 0.01), VAT (<i>p</i> < 0.05), subcutaneous adipose tissue (SAT) (<i>p</i> < 0.05) and total abdominal muscle (TAM) (<i>p</i> < 0.05) areas. Conclusion: This study demonstrates a link between ccRCC TTN gene mutation and shorter patient survival. The reduction of the analyzed tissues might be a risk of cancer cachexia in ccRCC patients with TTN gene mutation.https://www.mdpi.com/2076-3417/12/19/9502adipose tissueclear cell renal cell carcinomakidney cancermuscle massTTNVHL
spellingShingle Federico Greco
Alessandro Tafuri
Rosario Francesco Grasso
Bruno Beomonte Zobel
Carlo Augusto Mallio
Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
Applied Sciences
adipose tissue
clear cell renal cell carcinoma
kidney cancer
muscle mass
TTN
VHL
title Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
title_full Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
title_fullStr Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
title_full_unstemmed Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
title_short Clinicopathological and Body Composition Analysis of VHL and TTN Gene Mutations in Clear Cell Renal Cell Carcinoma: An Exploratory Study
title_sort clinicopathological and body composition analysis of vhl and ttn gene mutations in clear cell renal cell carcinoma an exploratory study
topic adipose tissue
clear cell renal cell carcinoma
kidney cancer
muscle mass
TTN
VHL
url https://www.mdpi.com/2076-3417/12/19/9502
work_keys_str_mv AT federicogreco clinicopathologicalandbodycompositionanalysisofvhlandttngenemutationsinclearcellrenalcellcarcinomaanexploratorystudy
AT alessandrotafuri clinicopathologicalandbodycompositionanalysisofvhlandttngenemutationsinclearcellrenalcellcarcinomaanexploratorystudy
AT rosariofrancescograsso clinicopathologicalandbodycompositionanalysisofvhlandttngenemutationsinclearcellrenalcellcarcinomaanexploratorystudy
AT brunobeomontezobel clinicopathologicalandbodycompositionanalysisofvhlandttngenemutationsinclearcellrenalcellcarcinomaanexploratorystudy
AT carloaugustomallio clinicopathologicalandbodycompositionanalysisofvhlandttngenemutationsinclearcellrenalcellcarcinomaanexploratorystudy